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INTRODUCTION
A family history of breast cancer is a clear
risk factor for developing the disease. In effect,
women who have a first degree relative with
breast cancer have a 2- to 3-fold higher risk of
developing the disease, while women who have
both the mother and a sister with breast cancer
are 14 times more likely to develop the disease
than patients without a family history of breast
cancer (Sattin et al., 1985). Therefore, when a
women is diagnosed of breast cancer, all her
female first degree relatives become individuals
at risk. This implies a number of important as-
pects to be taken into account by psycho-onco-
logy professionals. Four of these aspects will be
dealt with here: (a) Knowledge of the increased
risk of developing breast cancer can generate
much psychological distress; (b) These women
become the main target of secondary breast can-
cer prevention strategies, where periodic breast
controls are essential; (c) These women may
either over- or underestimate their true risk sta-
tus; and (d) these women may request genetic
testing to determine whether they carry genetic
mutations that cause some types of breast cancer.
PSYCHOLOGICAL DISTRESS IN WOMEN WITH
A FAMILY HISTORY OF BREAST CANCER
A number of studies have shown that women
with a family history of breast cancer can deve-
lop a broad range of psychopathological sym-
ptoms, including anxiety, intrusive and persistent
concern over breast cancer, fear and uncertainty,
feelings of guilt, helplessness against the disease,
despair, isolation and loneliness (Gagnon et al.,
1996; Kash et al., 1992; Kash et al., 1995; Ler-
man et al., 1993; Valdimarsdottir et al., 1995;
Wellisch et al., 1992; Zakowski et al., 1997).
Two different studies (Gagnon et al., 1996; Kash
et al., 1992) found women with a family history
of breast cancer to yield Brief Symptom Inven-
tory global scores similar to those of women
who had survived Hodgkin’s lymphoma or leu-
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kemia. Other data also suggest that women with
a family history of breast cancer may suffer
mood disturbances comparable to those seen in
patients recently diagnosed of breast cancer
(Lerman & Schwartz, 1993).
A number of factors may evidently cause
psychological distress in this population
(Gagnon et al., 1996), including the awareness of
being a high risk individual for a life-threatening
and potentially disfiguring illness; anticipation
of the disease in oneself; the caring for relatives
suffering from the disease; or personal identifi-
cation with the traumatic experiences of such af-
fected relatives.
In sum, in addition to the stress associated
with the diagnosis and treatment of breast cancer
in a close relative, female first-degree relatives
of breast cancer patients suffer the added stress
of learning that they are at risk of this same di-
sease. Psychological screening of these subjects
is therefore indicated, with attention to the psy-
chological problems they may present. In this
sense, some recent studies have proposed the de-
velopment of specific intervention programs for
the relatives of recently diagnosed breast cancer
patients (Schwartz et al., 1998).
On the other hand, research suggests that one
consequence of psychological distress in this po-
pulation may be decreased adherence to breast-
self examination and mammography (Kash et al.,
1992; Lerman et al., 1993).
SECONDARY BREAST CANCER PREVENTION
IN WOMEN WITH A FAMILY HISTORY OF
BREAST CANCER
The early detection of breast cancer is presen-
tly the most effective way to reduce mortality as-
sociated with the disease. Therefore, as risk indi-
viduals, women with a family history of breast
cancer become the central target of secondary
breast cancer prevention measures (Chart &
Franssen, 1997). However, studies show that a
substantial proportion of women with such a fa-
mily history do not adhere to recommended
mammographic screening. When considering
concrete statistics, the non-adherence percenta-
ges are seen to vary considerably from one study
to another: in the case of mammography, from
45% to 85% (Lerman & Schwartz, 1993). Simi-
lar considerations apply to clinical exploration -
though percentage adherence in this case seems
to be better than for mammographic screening –
and self-examination. Attempts have been made
to explain such diverging results in terms of cer-
tain psychological variables that seem to modu-
late the relation between a family history of
breast cancer and screening behavior (Lerman et
al., 1993). In this sense, emphasis has been pla-
ced on the important role play by (a) patient self-
perception of the level of risk; and (b) the psy-
chological distress or anxiety suffered by women
with a family history of the disease.
Thus, on one hand, it has been postulated that
the impact of a family history upon adherence to
screening may be mediated by perceived vulne-
rability to the disease. In this sense, the presence
of a given risk factor (in this case a family his-
tory of breast cancer) may be thought to likely
predispose to adherence only if the women are
aware of the importance of that factor for the de-
velopment of the disease (Costanza et al., 1992;
Taplin, Anderman & Grothaus, 1989). According
to Costanza et al. (1992), although the existence
of a family history of breast cancer is not asso-
ciated with mammographic screening, personal
awareness of the fact that such a history constitu-
tes a risk factor is indeed related to screening
adherence. These observations suggest that
knowledge or information concerning the risk
factors, and thus personal risk (perceived vulne-
rability), is the variable predicting the adoption
of preventive measures, rather than objective
risk as such. In the study by Lipkus, Rimer and
Strigo (1996), both objective and subjective
breast cancer risk was seen to be individually
associated with the use of mammography; how-
ever, when objective and subjective risk were
included in a multivariate model, only subjective
risk predicted adherence to mammography.
However, as in the case of the general popula-
tion, the role of this variable is complex. In ef-
fect, while some studies have reported a positive
relation between perceived vulnerability and
adherence to screening others have found that
intense perceived vulnerability to breast cancer
may inhibit the use of screening among high risk
women (Hailey, 1991).
On the other hand, on assessing perceived risk
among women with a family history of breast
cancer, these individuals have been observed to
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systematically overestimate the true risk of the
disease (Bondy et al., 1992; Evans et al., 1993;
Gagnon et al., 1996; Stefanek, 1990). Specifi-
cally, the study of Evans et al. (1993) found only
11% of the women in the series to be able to
correctly estimate risk, while 45% overestimated
it. In the more recent study by Gagnon et al.
(1996), mean perceived risk among the partici-
pating women was 55%, while the true mean
risk (derived from empirical tables) was only
18%; in turn, 75% of these women subjectively
estimated risk to be more than double the true
risk. A number of authors have pointed out that
such incorrect perception and overestimation of
risk could contribute to increase psychological
distress in a population subgroup that – as has
already been pointed out – often exhibits a broad
range of psychopathological symptoms. Empiri-
cal research has shown the relation between a
family history of breast cancer, psychological
distress and screening behavior to be complex.
While some authors consider that the probability
of adherence to screening recommendations
decreases with increasing psychological distress
symptoms (Kash et al., 1992; Lerman et al.,
1990, 1993), others describe a positive associa-
tion between the two variables (Stefanek & Wil-
cox, 1991).
These conflicting results were initially inter-
preted in terms of the classical «Fear-arousing
Communications» Theory (Janis & Feshbach,
1953). According to this theory, a nonlinear rela-
tion exists between anxiety and preventive beha-
vior, where moderate psychological distress
would be optimum for activating preventive be-
havior, while low distress levels could fail to ge-
nerate sufficient motivation for behavioral chan-
ge, and excessively intense distress could lead to
avoidance of information relating to the threat
(Hailey, 1991; Lerman & Schwartz, 1993). Tho-
se authors, whose own empirical results proved
contradictory, subsequently agreed that their
observed differences in anxiety level justified the
results obtained, and that in both cases the fin-
dings point to a nonlinear relation between an-
xiety and preventive behavior (Kash, 1992; Ler-
man, Kash & Stefanek, 1994; Stefanek, 1992).
More recently, Leventhal’s «Self-regulation
Theory» (Leventhal, 1970; Leventhal, Meyer &
Nerenz, 1980) was proposed with the principal
aim of understanding the process by which peo-
ple define and represent disease threats and how
they cope with such threats. As such, the theory
may constitute a more adequate reference in the
specific context of women with a family history
of breast cancer. In effect, according to Leven-
thal, and considering that the individual reacts
both cognitively and emotionally to health com-
munications, two parallel channels or indepen-
dent systems would exist for the processing of
information, and both could occasionally inter-
fere with each other. One of the systems or
channels would give rise to the elaboration of an
objective representation of the health threat and
to the development of coping responses for con-
trolling the threat (i.e., threat control), while the
second system or channel would involve proces-
sing of the emotional reactions to the threat and
the implementation of coping strategies to con-
trol such reactions (fear control). As pointed out
by Shiloh, Vinter and Barak (1997), screening
behaviors are a good candidate for the develo-
pment of interference between both channels or
systems, since occasionally screening avoidance
may be a more effective strategy for controlling
fear – thereby preventing the implementation of
coping strategies to deal with the objective
threat.
In sum, while a moderate level of breast can-
cer fear or distress may contribute to the deve-
lopment of preventive behavior, intense distress
associated with marked perceived vulnerability
to breast cancer may lead to the avoidance of
screening as a way to cope with fear of the threat
of disease. Mammographic screening may pose a
threat particularly to women with a high risk of
developing breast cancer, since the technique is
unable to reduce the probability of developing
the disease. This may cause such women to try
to control their fear by avoiding anxiety-genera-
ting actions – of which mammographic scre-
ening may constitute an example.
BREAST CANCER RISK COUNSELING
The existence of such complex relationships
between perceived vulnerability, psychological
distress and adherence to screening in women
with a family history of breast cancer has pro-
duced the need for specific intervention pro-
grams for this high risk population. Most such
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programs have adopted the traditional medical
model of genetic counseling – their central aim
being empirical assessment of the true or statis-
tical risk of breast cancer, with risk notification
to the woman in order to adjust her perceived
vulnerability to the true risk, and to promote ear-
ly breast cancer detection behavior. In general,
these programs include a few sessions (someti-
mes only one) in which risk quantification, pa-
tient notification and the recommendation and
instruction of preventive behavior is conducted
by a health professional on an individualized ba-
sis.
As regards the quantification of statistical
risk, the two most commonly used systems have
been recently developed by Gail et al. (1989)
and Clauss et al. (1990, 1994). Both are statisti-
cal estimates of breast cancer risk based on a se-
ries of factors. The first approach constitutes a
multifactor system involving five variables: the
number of first degree relatives with breast can-
cer, the current age of the woman, her age at me-
narche, age at term of first pregnancy, and the
number of previous breast biopsies performed.
The system developed by Clauss et al. in turn
contemplates only the number of first or second
degree relatives with breast cancer, the age of the
affected relative/s at the time of diagnosis of the
disease, and the age of the woman at the time of
risk assessment.
A number of authors have published results
suggesting that individualized breast cancer risk
counseling improves understanding of the risk of
breast cancer, thereby improving agreement bet-
ween real and perceived risk (Evans et al., 1994;
Gagnon et al., 1996; Lerman et al., 1995). How-
ever, such programs also have limitations. In ef-
fect, a number of studies have found that risk
counseling does not increase adherence to breast
cancer screening  (Evans et al., 1994; Gagnon et
al., 1996), while others report that although per-
ceived risk is better adjusted to true risk as a re-
sult of counseling, many women continue to ha-
ve mistaken perceptions of breast cancer risk and
have difficulties remembering the notified risk
level (Cull et al., 1999; Hallowell et al., 1997;
Lloyd et al., 1996; Watson et al., 1999). Such li-
mitations point to the need for taking into ac-
count the psychological aspects implicated in
risk counseling programs – particularly when
considering the results obtained by Lerman et al.
(1995), who found that the subgroup of women
who before counseling already exhibited high le-
vels of concern and anxiety over breast cancer
were the only patients who failed to benefit
from counseling. The authors suggest that the
high distress levels in these women may have
interfered with their capacity to assimilate the
information provided, and point to the need for
developing and assessing strategies to deal with
the psychological challenges posed by risk coun-
seling.
In this sense, the most recent approaches to
breast cancer risk counseling emphasize the
need to combine risk counseling and psycholo-
gical counseling, in a continuous process over ti-
me and involving long-term assessments (Ben-
nett, Gattas & Teh, 1999; Hopwood et al., 1998;
Watson et al., 1998). Of the programs for women
with a high risk of developing breast cancer that
combine risk and psychological counseling, em-
phasis should be placed on the Strang Cancer
Prevention Center (New York) protocol, since a
first assessment of this program has already
been published (Kash et al., 1995). The program,
based on six consecutive weekly sessions, sets
the following objectives: reduced emotional
stress and anxiety, lessened perceived vulnera-
bility to breast cancer, modification of health
beliefs, and increased adherence to screening. 
In order to achieve these aims, the program
combines individual psychotherapy with group
psychoeducational intervention based on Leven-
thal’s «Self-regulation Theory» (Leventhal, Die-
fenbach & Leventhal, 1992), involving three
components: education, cognitive restructuring
and emotional support. The educational compo-
nent provides the woman with information con-
cerning her relative risk, clarifying her know-
ledge of the disease and other risk factors, detai-
ling healthy life styles and modifying eating
habits; instruction on self-exploration techni-
ques, and emphasis on the importance of adhe-
rence to the recommended screening regimens.
Cognitive restructuring in term aims to reduce
anxiety and the feeling of helplessness, and to
help women solve problems, encouraging them
to use active coping strategies instead of avoi-
ding or denying risk status. Finally, emotional
support attempts to reduce the feeling of isola-
tion, encouraging the patient to share her fe-
elings and thoughts with others, and to establish
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communicative and supportive relations with
other women. 
A pilot study applying this program was able
to reduce perceived vulnerability, adjusting it to
the true statistical risk, correcting false percep-
tions regarding breast cancer, and boosting adhe-
rence to screening techniques over the following
three-year period. At present, the authors are
evaluating the program based on a control group
randomization design, with promising prelimina-
ry results.
GENETIC TESTING IN WOMEN WITH A
FAMILY HISTORY OF BREAST CANCER
Lastly, considering that recent advances in
molecular biology have shown that some breast
cancers may develop as a result of mutations of
several specific gene loci, many women with a
family history of breast cancer could request ge-
netic testing to determine whether they carry
such mutations. However, only a small propor-
tion of breast cancers (between 5% and 10%) are
attributable to genetic mutations. In addition, the
tests developed to date for evaluating mutation
carrier status are complicated, expensive and not
available in all oncological centers. Consequen-
tly, it is necessary to determine who should un-
dergo genetic testing, and particularly the condi-
tions under which testing should occur.
A number of authors have proposed assigning
genetic testing on two basic context (Lynch &
Lynch, 1996): (1) families thought to most likely
present a hereditary syndrome predisposing to
cancer; and (2) family members who have given
informed consent before testing and before dis-
closure of the test results. The chance of carrying
a genetic mutation varies markedly from woman
to woman, depending on the family history of
breast cancer and related cancers. In this context,
risk-prediction algorithms that fully reflect our
knowledge of the nature of the inheritance
mechanism may contribute in an important way
to decide genetic testing. Models for estimating
the individual probability of carrying a BRCA1
or BRCA2 mutation are being developed (Par-
migiani, Berry & Aguilar, 1998); in view of the
expense of testing and the possibility of uninfor-
mative results, such estimates may be quite use-
ful. On the other hand, genetic testing should be
performed in centers where physicians are highly
experienced in oncology and genetics and have
worked intensively with cancer-prone families.
Ideally, such groups should have consultants
who are skilled genetic counselors, social wor-
kers, and psychologists who are knowledgeable
about how this genetic information might affect
insurability, employability, intrafamily conflicts,
and emotions.
In recent years, many countries have seen the
emergence of Cancer Family Clinics, usually run
jointly by an oncological surgeon, oncologist and
a geneticist. The purpose of such clinics (Ben-
nett, Gattas & Teh, 1999) is to: provide indivi-
duals with information about familial aspects of
cancer; assess their statistical risk of developing
breast cancer; offer genetic testing where appro-
priate; make recommendations regarding the
need for either ongoing surveillance (screening)
or more active interventional therapies (prophy-
lactic surgery or chemoprevention); and alleviate
anxiety, since many women may have an inap-
propriately high expectation of their degree of
risk – and most such women can be greatly
reassured as a result of counseling in the clinic.
Although such centers have proliferated in
many countries in recent years, no studies have
yet been made to assess their results. The psy-
chological aspects of cancer genetics practices
remain to be addressed. Prospective studies with
an adequate duration of follow-up will be requi-
red to assess outcomes, and to help define vulne-
rable subgroups that may exhibit poor adjus-
tment to risk counseling and/or genetic testing
and intervention (Beckmann et al., 1996; Lerman
& Croyle, 1994; Hopwood, 1997).
Furthermore, breast cancer genetic counseling
raises a series of ethical issues in which the
questions presently outnumber the answers:
Should a woman be informed of the risk of
breast cancer if she cannot at the same time re-
ceive options for avoiding the disease? Is it an
obligation to inform the relatives of breast
cancer patients of their risk of developing the
disease? To what extent should women with a
genetic risk of developing breast cancer be sub-
jected to chemoprevention or other procedures?
In an article addressing these aspects, Lerman,
Rimer and Engstrom (1991) suggested that ap-
plication of the principles of informed consent
theory to genetic counseling in cancer might
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help clarify some of these ethical questions.
Thus, the non-maleficence principle requires the
notification of personal risk to imply no psycho-
logical sequelae, with the need to intervene upon
such sequelae if they arise. In turn, the informed
and autonomous decision-taking principle im-
plies that the communication process must gua-
rantee adequate comprehension of the informa-
tion provided, while the principle of confiden-
tiality obliges observance of the right to intimacy
and non-discrimination.
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ABSTRACT
A family history of breast cancer is a clear risk for
developing the disease. Therefore, when a woman is
diagnosed with breast cancer all her female first de-
gree relatives become population at risk. This involve
a number of important aspects to be taken into account
by psychooncology professionals. (a) First, in addition
to the stress  associated with the diagnosis and treat-
ment of breast cancer in a close relative, first degree
relatives of breast cancer patients have the added
stress of learning that they are at risk of this disease.
(b) Second, these women become the main target of
secondary breast cancer prevention strategies. How-
ever, various reports show that a considerable percen-
tage of these women do not follow the recommended
screening methods. For this reason, it is necesary to
study the possible contribution of psychosocial factors,
specially health beliefs, in the practice of preventive
behavior aimed at preventing breast cancer in this po-
pulation, and to design strategies to promote preven-
tive practices. (c) Most of the research on health be-
liefs among women at risk for breat cancer has focused
on risk perception. This research as found that some
women with a family history of breast cancer have
significantly overestimated their risk, while others
have underestimated their risk. The need to provide
risk counselling schemes for these women is therefore
proposed, in order to estimate and advise them of their
real risk. (d) Finally, these women may request genetic
testing to determine whether they carry genetic muta-
tions (BRCA1, BRCA2, or others) that cause some
types of breast cancer. However, it must be remembe-
red that, although many first degree relatives will have
heard of and seek «the cancer gene test», currently tes-
ting is appropiate and available only for rare indivi-
duals. All these issues are reviewed in the present pa-
per. 
Key words: Breast cancer, psychology, risk coun-
selling, genetic counselling.
RESUMO
Uma história familiar de cancro da mama é um factor
de risco para o desenvolvimento da doença. Assim,
quando é diagnosticado um cancro da mama a uma
mulher, todas as mulheres suas familiares em primeiro
grau são uma população em risco. Isto implica as-
pectos importantes que devem ser tidos em conta pelos
profissionais de psico-oncologia. (a) Juntamente com o
stress associado ao diagnóstico e tratamento do cancro
numa familiar próxima, estas mulheres experimentam
também o stress de saberem que também têm risco de
desenvolverem a doença. (b) Estas mulheres tornam-
-se, portanto, um grupo-alvo de estratégias de preven-
ção secundária do cancro da mama. Por esta razão, é
necessário estudar a influência de factores psicosso-
ciais, especialmente das crenças de saúde, na prática
de comportamentos especificamente direccionados
para a prevenção do cancro da mama nessa população
e, ao mesmo tempo, também é necessário delinear es-
tratégias que promovam práticas preventivas. (c) A
maior parte da investigação sobre as crenças de saúde
de mulheres em risco de desenvolverem cancro da ma-
ma tem-se centrado na percepção de risco. Este estudo
mostra que algumas mulheres com história familiar de
cancro da mama sobrestimam significativamente o seu
risco, enquanto outras o subestimam. Faz-se uma pro-
posta de aconselhamento de risco, com a finalidade de
avaliá-lo e aconselhar essas mulheres sobre o seu risco
real. (d) Finalmente, estas mulheres podem necessitar
de realizar testes genéticos para averiguar se são porta-
doras de marcadores relacionados com certos tipos de
cancro da mama. Contudo, deve ser lembrado que, em-
bora várias familiares em primeiro grau já tenham ou-
vido falar e solicitem fazer «o teste do gene do can-
cro», a sua realização só está indicada para algumas.
Todos estes aspectos são revistos neste artigo.
Palavras-chave: Cancro da mama, psicologia, acon-
selhamento de risco, aconselhamento genético.
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